https://orcid.org/0000-0002-6774-9847
Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, Talha Bin Emran, Saikat Mitra, Ali A. Rabaan, Saad Alhumaid, Zainab Al Alawi & Abbas Al Mutair. (2022) COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Vivek P. Chavda, Aayushi B. Patel, Lalitkumar K. Vora, Vasso Apostolopoulos & Bruce D. Uhal. (2022) Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management. Expert Review of Vaccines 21:10, pages 1395-1403.
Read now
Read now
Arvind Kumar Singh, Manoj Kumar Panigrahi, Somen Kumar Pradhan, Debkumar Pal, Sonu H. Subba, Binod Kumar Patro, Binod Kumar Behera, Baijayantimala Mishra, Bijayini Behera, Prasanta Raghab Mohapatra, Sourin Bhuniya, Shakti Kumar Bal, Saurav Sarkar, Jawahar S. K Pillai, Sachidananda Mohanty & Batmanabane Gitanjali. (2022) Clinico-Epidemiological Characteristics of Healthcare Workers with SARS-CoV-2 Infection during the First and Second Waves in a Teaching Hospital from Eastern India: A Comparative Analysis. Hospital Topics 0:0, pages 1-12.
Read now
Read now
Purva Asrani, Keshav Tiwari, Mathew Suji Eapen, M.D. Imtaiyaz Hassan & Sukhwinder Singh Sohal. (2022) Containment strategies for COVID-19 in India: lessons from the second wave. Expert Review of Anti-infective Therapy 20:6, pages 829-835.
Read now
Read now
Ferhat Arslan, Burcu Isık Goren, Begumhan Baysal & Haluk Vahaboğlu. (2022) Is vaccination necessary for COVID-19 patients? A retrospective cohort study investigating reinfection rates and symptomatology in a tertiary hospital. Expert Review of Vaccines 21:2, pages 249-252.
Read now
Read now
Mohd Raeed Jamiruddin, Md Ahsanul Haq, Kazuhito Tomizawa, Eiry Kobatake, Masayasu Mie, Sohel Ahmed, Shahad Saif Khandker, Tamanna Ali, Nowshin Jahan, Mumtarin Jannat Oishee, Mohib Ullah Khondoker, Bijon Kumar Sil, Mainul Haque & Nihad Adnan. (2021) Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG. Journal of Inflammation Research 14, pages 2497-2506.
Read now
Read now
Articles from other publishers (31)
Debrupa Dutta, Anisa Ghosh, Chiroshri Dutta, Soumi Sukla & Subhajit Biswas. (2023) Cross‐reactivity of SARS‐CoV‐2 with other pathogens, especially dengue virus: A historical perspective. Journal of Medical Virology 95:2.
Crossref
Crossref
Muhammad Mumtaz Adzdzakiy, Isnaini Zakiyyah Asyifa, Alvira Rifdah Sativa, Ahmad Ridha Al Fiqri, Anik Budhi Dharmayanthi, Anggia Prasetyoputri & Sugiyono Saputra. SARS-CoV-2 infections in certain groups: A review from COVID-19 study cases. SARS-CoV-2 infections in certain groups: A review from COVID-19 study cases.
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, Mohd. Iqbal Yatoo, Ranjan K. Mohapatra, Sandip Chakraborty, Hao Zhou, Md. Rabiul Islam, Sukamto S. Mamada, Hendrix Indra Kusuma, Ali A. Rabaan, Saad Alhumaid, Abbas Al Mutair, Muhammad Iqhrammullah, Jaffar A. Al-Tawfiq, Mohammed Al Mohaini, Abdulkhaliq J. Alsalman, Hardeep Singh Tuli, Chiranjib Chakraborty & Harapan Harapan. (2023) Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. Journal of Infection and Public Health 16:1, pages 4-14.
Crossref
Crossref
Jiaming Ge, Tianbao Song, Mengyuan Li, Weisan Chen, Jiarong Li, Sihan Gong, Ying Zhao, Lin Ma, Hongjian Yu, Xiankuan Li & Kun Fu. (2023) The medicinal value of tea drinking in the management of COVID-19. Heliyon 9:1, pages e12968.
Crossref
Crossref
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, Deepika Bohra & Nirmal Kumar Ganguly. (2022) Omicron variant: Current insights and future directions. Microbiological Research 265, pages 127204.
Crossref
Crossref
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, Fahad A. Alhumaydhi, Talha Bin Emran & Polrat Wilairatana. (2022) Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?. Biomedicine & Pharmacotherapy 154, pages 113522.
Crossref
Crossref
Claire Quiner, Kasey Jones & Georgiy Bobashev. (2022) Impacts of timing, length, and intensity of behavioral interventions to COVID-19 dynamics: North Carolina county-level examples. Infectious Disease Modelling 7:3, pages 535-544.
Crossref
Crossref
Joshua Hirsh, Thwe Htay, Shubhang Bhalla, Victoria Nguyen & Jorge Cervantes. (2023) Breakthrough SARS-CoV-2 infections after COVID-19 immunization. Journal of Investigative Medicine 70:6, pages 1429-1432.
Crossref
Crossref
Anna Y. Popova, Omor T. Kasymov, Vyacheslav Y. Smolenski, Vyacheslav S. Smirnov, Svetlana A. Egorova, Zuridin S. Nurmatov, Anzhelika M. Milichkina, Gulmira S. Suranbaeva, Tatiana E. Kuchuk, Irina V. Khamitova, Elena V. Zueva, Valery A. Ivanov, Zhanylai N. Nuridinova, Aisuluu A. Derkenbaeva, Victoria G. Drobyshevskaya, Gulsun Z. Sattarova, Marat T. Kaliev, Alexandra V. Gubanova, Oyuna B. Zhimbaeva, Alexandra P. Razumovskaya, Vyacheslav N. Verbov, Ivan V. Likhachev, Alexey V. Krasnov & Areg A. Totolian. (2022) SARS-CoV-2 herd immunity of the Kyrgyz population in 2021. Medical Microbiology and Immunology 211:4, pages 195-210.
Crossref
Crossref
Andri Frediansyah, Fajar Sofyantoro, Saad Alhumaid, Abbas Al Mutair, Hawra Albayat, Hayyan I. Altaweil, Hani M. Al-Afghani, Abdullah A. AlRamadhan, Mariam R. AlGhazal, Safaa A. Turkistani, Abdulmonem A. Abuzaid & Ali A. Rabaan. (2022) Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review. Molecules 27:13, pages 4305.
Crossref
Crossref
Justine M. McKittrick, Thomas W. Burke, Elizabeth Petzold, Gregory D. Sempowski, Thomas N. Denny, Christopher R. Polage, Ephraim L. Tsalik & Micah T. McClain. (2022) SARS‐CoV‐2 reinfection across a spectrum of immunological states. Health Science Reports 5:4.
Crossref
Crossref
Rekha Khandia, Shailja Singhal, Taha Alqahtani, Mohammad Amjad Kamal, Nahed A. El-Shall, Firzan Nainu, Perumal Arumugam Desingu & Kuldeep Dhama. (2022) Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic. Environmental Research 209, pages 112816.
Crossref
Crossref
Adèle de Malherbe, S. Verdun, V. Brenière, L. Luquel, M. Jourdan & M. Harboun. (2022) COVID-19 Prevalence in UNIVI Group Nursing Homes and Multilevel Geriatric Hospitals: Epidemiological Study of Immunological Status with Rapid Serological Tests for Diagnostic Guidance and Follow Up. The journal of nutrition, health & aging 26:5, pages 477-484.
Crossref
Crossref
Jialu Huang, Yubo Ding, Jingwei Yao, Minghui Zhang, Yu Zhang, Zhuoyi Xie & Jianhong Zuo. (2022) Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19. Vaccines 10:3, pages 405.
Crossref
Crossref
Mateusz Babicki, Wojciech Malchrzak & Agnieszka Mastalerz-Migas. (2022) Assessment of Attitudes, Main Concerns and Sources of Knowledge Regarding COVID-19 Vaccination in Poland in the Unvaccinated Individuals—A Nationwide Survey. Vaccines 10:3, pages 381.
Crossref
Crossref
Goutham V. Ganesh & Ramkumar K. Mohanram. (2021) Metabolic reprogramming and immune regulation in viral diseases. Reviews in Medical Virology 32:2.
Crossref
Crossref
Valéria O. Silva, Rosemeire Yamashiro, Cintia M. Ahagon, Ivana B. de Campos, Isabela P. de Oliveira, Elaine L. de Oliveira, Giselle I. S. López‐Lopes, Elaine M. Matsuda, Marcia J. Castejon & Luís F. de Macedo Brígido. (2021) Inhibition of receptor‐binding domain—ACE2 interaction after two doses of Sinovac's CoronaVac or AstraZeneca/Oxford's AZD1222 SARS‐CoV‐2 vaccines. Journal of Medical Virology 94:3, pages 1217-1223.
Crossref
Crossref
Mohammed Yousif Elnaeem Yousif, Mohammed Mahmmoud Fadel Allah Eljack, Mazin S. Haroun, Khabab Abbasher Hussien Mohamed Ahmed, Osman Amir, Mohammed Alfatih, Akram Khalid Al Tigany Al Shiekh, Mazin Abdelraham Osman Ahmed, Alshareef Nour, Radi Tofaha Alhusseini, Waddah Aljaely Mohammed Osman, Mohamed Abdulkarim, Mohammed Eltahier Abdalla Omer & Ibrahim M. Mahgoub. (2022)
Retracted:
Clinical Characteristics and Risk Factors Associated with Severe Disease Progression among
COVID
‐19 Patients In Wad Medani Isolation Centers: A M
ulticenter
Retrospective C
ross‐Sectional
Study
. Health Science Reports 5:2.
Crossref
Crossref
Irene García-García, Enrique Seco-Meseguer, Pilar Ruiz-Seco, Gema Navarro-Jimenez, Raúl Martínez-Porqueras, María Espinosa-Díaz, Juan José Ortega-Albás, Iñigo Sagastagoitia, María Teresa García-Morales, María Jiménez-González, Lucía Martínez de Soto, Ana Isabel Bajo-Martínez, María del Palacio-Tamarit, Raquel López-García, Lucía Díaz-García, Javier Queiruga-Parada, Christine Giesen, Ana Pérez-Villena, Marta de Castro-Martínez, Juan J. González-García, Miguel Rodriguez-Rubio, Pedro de la Oliva, José R. Arribas, Antonio J. Carcas & Alberto M. Borobia. (2022) Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial. Journal of Clinical Medicine 11:4, pages 1139.
Crossref
Crossref
Xin-Xin Wu, Jin-Jian Yao, Jin Qian, Qi-Feng Huang, Tang Deng, Shuang-Qin Xu, Hang-Fei Wang, Qi Li, Ji-Chao Peng, Yang Yi, Nan Li, Yue Huang & Xiao-Ran Liu. (2022) Incidence of adverse reactions to COVID-19 vaccination: A meta-analysis of randomized controlled trials. Journal of Acute Disease 11:1, pages 1.
Crossref
Crossref
Helena A. Saunders & Jean-Marc Schwartz. (2021) COVID-19 vaccination strategies depend on the underlying network of social interactions. Scientific Reports 11:1.
Crossref
Crossref
Kwang Yoo, Nikita Thapa, Beom Kim, Jung Lee, You Jang, Yong Chwae & Jaeyoung Kim. (2021) Possibility of exosome‑based coronavirus disease 2019 vaccine (Review). Molecular Medicine Reports 25:1.
Crossref
Crossref
Fahadul Islam, Shabana Bibi, Atkia Farzana Khan Meem, Md. Mohaimenul Islam, Md. Saidur Rahaman, Sristy Bepary, Md. Mizanur Rahman, Md. Mominur Rahman, Amin Elzaki, Samih Kajoak, Hamid Osman, Mohamed ElSamani, Mayeen Uddin Khandaker, Abubakr M. Idris & Talha Bin Emran. (2021) Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19. International Journal of Molecular Sciences 22:23, pages 12638.
Crossref
Crossref
Md. Takim Sarker, A. Q. Fuad Hasan, Md. Oliullah Rafi, Md. Jamal Hossain, H. R. Abd El-Mageed, Reem M. Elsapagh, Raffaele Capasso & Talha Bin Emran. (2021) A Comprehensive Overview of the Newly Emerged COVID-19 Pandemic: Features, Origin, Genomics, Epidemiology, Treatment, and Prevention. Biologics 1:3, pages 357-383.
Crossref
Crossref
Maureen Rebecca Smith, Maria Trofimova, Ariane Weber, Yannick Duport, Denise Kühnert & Max von Kleist. (2021) Rapid incidence estimation from SARS-CoV-2 genomes reveals decreased case detection in Europe during summer 2020. Nature Communications 12:1.
Crossref
Crossref
Andri Frediansyah. (2021) The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review. Clinical Epidemiology and Global Health 12, pages 100826.
Crossref
Crossref
Alberto Salvadori, Paolo Fanari, Paolo Marzullo, Franco Codecasa, Ilaria Tovaglieri, Mauro Cornacchia, Ileana Terruzzi, Anna Ferrulli, Patrizia Palmulli, Amelia Brunani, Stefano Lanzi & Livio Luzi. (2021) Playing around the anaerobic threshold during COVID-19 pandemic: advantages and disadvantages of adding bouts of anaerobic work to aerobic activity in physical treatment of individuals with obesity. Acta Diabetologica 58:10, pages 1329-1341.
Crossref
Crossref
Shafi Mahmud, Gobindo Kumar Paul, Suvro Biswas, Shamima Afrose, Mohasana Akter Mita, Md. Robiul Hasan, Mst. Sharmin Sultana Shimu, Alomgir Hossain, Maria Meha Promi, Fahmida Khan Ema, Kumarappan Chidambaram, Balakumar Chandrasekaran, Ali M. Alqahtani, Talha Bin Emran & Md. Abu Saleh. (2021) Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Christopher Hopkins, Chidinma Onweni, Victoria Zambito, DeLisa Fairweather, Kathryn McCormick, Hideki Ebihara, Thomas Caulfield, Yu Shrike Zhang & W. David Freeman. (2021) Platforms for Personalized Polytherapeutics Discovery in COVID-19. Journal of Molecular Biology 433:10, pages 166945.
Crossref
Crossref
Shafi Mahmud, Gobindo Kumar Paul, Mirola Afroze, Shirmin Islam, Swagota Briti Ray Gupt, Mamudul Hasan Razu, Suvro Biswas, Shahriar Zaman, Md. Salah Uddin, Mala Khan, Nunzio Antonio Cacciola, Talha Bin Emran, Md. Abu Saleh, Raffaele Capasso & Jesus Simal-Gandara. (2021) Efficacy of Phytochemicals Derived from Avicennia officinalis for the Management of COVID-19: A Combined In Silico and Biochemical Study. Molecules 26:8, pages 2210.
Crossref
Crossref
Dhigishaba Jadeja & Payel Basak. (2021) Symptomatic Reinfection in Previously Recovered Coronavirus Disease 2019 (COVID-19) Geriatric Patient. Cureus.
Crossref
Crossref